Ads
related to: eosinophilic airway inflammation treatment- Dosing & Administration
View Dosing & Administration Info
For A Severe Asthma Medication.
- Eosinophil Diseases
Learn About A Treatment For
Multiple Eosinophil-Driven Diseases
- Eosinophilic Asthma Info
Read About A Treatment For Severe
Eosinophilic Asthma To Learn More.
- Adverse Reaction Info
Explore Safety Information For
A Severe Asthma Treatment.
- Clinical Trial Data
View Clinical Trial Data For A
Severe Eosinophilic Asthma Med.
- Treatment Admin Options
Uncover An SEA Treatment That
May Fit Your Patient's Schedule.
- Dosing & Administration
reviewscout.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Eosinophilic bronchitis (EB) is a type of airway inflammation due to excessive mast cell recruitment and activation in the superficial airways as opposed to the smooth muscles of the airways as seen in asthma. [1] [2] It often results in a chronic cough. [1] Lung function tests are usually normal. [1] Inhaled corticosteroids are often an ...
Acute eosinophilic pneumonia (AEP) is an uncommon, acute-onset form of eosinophilic lung disease which varies in severity. Though poorly understood, the pathogenesis of AEP likely varies depending on the underlying cause which may include smoking, inhalation exposure, medication, and infection. [ 1 ]
When eosinophilic pneumonia is related to an illness such as cancer or parasitic infection, treatment of the underlying cause is effective in resolving the lung disease. When due to acute or chronic eosinophilic pneumonia, however, treatment with corticosteroids results in a rapid, dramatic resolution of symptoms over the course of one or two days.
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as allergic granulomatosis, [3] [4] is an extremely rare autoimmune condition that causes inflammation of small and medium-sized blood vessels in persons with a history of airway allergic hypersensitivity . [5] It usually manifests in three stages.
No universal treatment guidelines have been established for tropical pulmonary eosinophilia. [3] The antifilarial diethylcarbamazine (6 mg/kg/day in three divided doses [2] for 21 days [8] remains the main therapeutic agent, and is generally well tolerated. Reported side effects include headache, fever, pruritus and gastrointestinal upset. [14]
IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and survival of eosinophils. Eosinophils play a role in the mediation of inflammation in the airways. Eosinophilic asthma is a phenotype of asthma that is characterized by the higher than normal presence of eosinophils in the lung and sputum.
Ads
related to: eosinophilic airway inflammation treatment